Cancer diagnostics group VolitionRx Limited (NYSE MKT:VNRX) has appointed David Vanston as its new chief financial officer with immediate effect.
Vanston joins from Octo Telematics, a technology company based in Boston, where he was the Senior Controller for its US business.
Before this, he spent 20 years with globally-listed companies in a variety of sectors spanning manufacturing and technology to life sciences .
Cameron Reynolds, Volition’s chief executive, expressed confidence that Vanston would add value as VolitionRx becomes a revenue-generating company.
Former CFO David Kratochvil tendered his resignation in November, but stayed on until a successor was found.